Baxter International (Vero cell technology) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Baxter International (Vero cell technology) General Information

Description

Producer and provider of vaccines. The unit is an advanced, cell-based technology for vaccines production. It is used to produce vaccines including H5N1, H1N1 and seasonal influenza. It includes Baxter's production facility in Bohumil, Czech Republic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Bohumil
  • Czech Republic
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Baxter International (Vero cell technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baxter International (Vero cell technology)‘s full profile, request access.

Request a free trial

Baxter International (Vero cell technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baxter International (Vero cell technology)‘s full profile, request access.

Request a free trial